0.9% Sodium Chloride Intravenous Infusion Solution
Sponsors
Sint Antonius Ziekenhuis Stichting, Centre Hospitalier Universitaire De Nantes, Linkopings Universitet, Glycomine Inc., Immunocore Limited
Conditions
BronchiectasisGambling disorderHealthy volunteersPMM2-CDGPatients operated with an IPAA for ulcerative colitis woth active recurrent pouchitis.Type 1 Diabetesiron deficiency anaemia
Phase 1
Phase 2
Effects of the appetite-inducing hormone ghrelin on decision making in healthy volunteers
CompletedCTIS2024-517598-26-00
Start: 2019-08-26End: 2025-08-13Target: 74Updated: 2024-10-21
Morphine effects on stress response and social interaction – an exploratory randomized controlled experimental medicine study
Active, not recruitingCTIS2024-517855-10-00
Start: 2022-04-20Target: 36Updated: 2024-10-25
A Phase 2b, Multicenter, Double-blind, Randomized, Placebo controlled Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 Administered Intravenously to Participants with PMM2-CDG
RecruitingCTIS2024-520109-37-00
Start: 2025-07-09Target: 45Updated: 2026-01-27
Phase 3
Prospective multicenter randomized controlled double-blind label study of the prophylaxis of recurrent pouchitis after fecal microbiota transplant in UC with ileo-anal anastomosis.
RecruitingCTIS2024-517078-52-00
Start: 2026-01-19Target: 42Updated: 2025-03-06
Randomized, double-blind, parallel-group clinical trial, compared with placebo to evaluate the efficacy and safety of three antibiotic treatment regimens for the eradication of primary P. aeruginosa infection in patients with bronchiectasis
Not yet recruitingCTIS2025-524454-34-00
Target: 160Updated: 2026-06-09